Slide Shop Now High-Priority Service for Scientific Research Primary Cells for True Research Outcomes, Tailored Media to Optimize Primary Cell Life Human Neonatal Melanocytes
Save 15% on Human Hematopoietic Peripheral Blood Cells. Use HPBC122 to order online by January 31
Save 15% on Human Hematopoietic Peripheral Blood Cells
Use "HPBC122" to order online by January 31.

Highly-Tailored Cells and Media for the Best Possible Research Outcomes

GET FAST ACTION: Talk to a real person today. Get a quote today.

WE’VE BEEN RESEARCHERS, TOO FOR 25+ YEARS: We know the value of specializing in Primary Cells and creating media specifically for each Primary Cell type . . .

  1. CHOOSE PRIMARY CELLS FOR TRUE OUTCOMES: unexposed to phenol red with limited exposure to antimicrobials.
  2. TAILOR CELL SELECTION to Your Research: Choose Primary Cells by a representative sample of the population or by donor demographic information.
  3. CHOOSE MEDIA DESIGNED FOR EACH PRIMARY CELL TYPE: to prolong primary cell life. Each medium is composed and supplemented to maximize the life expectancy of a particular primary cell type.
  4. ENJOY BETTER PERFORMANCE: Primary cells cultured in Lifeline® medium will out-perform cells grown in similar media: cells plate better, grow more quickly, maintain better morphology, for consistently reproducible results.

Avoid waiting for a call back (or choosing media not tailored for your particular Primary Cells, or cells not tailored for your research).

Call us today for High-Priority Service: 877-845-7787

FROM OUR BLOG

January – National Blood Donor Month

Welcome back to the Lifeline Blog–it’s the start of a brand-new year! To kick off another exciting year of posts highlighting life sciences research, we wanted to shine a spotlight on January as National Blood Donor Month. The American Red Cross and Blood Banks of America encourage everyone who is eligible to consider blood donation…

Semi-Annual Review of Lifeline Products Featured in 2021

2021 has been a monumental year for science with the landmark approvals of not one, but two COVID-19 vaccines in the US with many other candidates in the clinical pipeline. The speed at which we went from mRNA sequence selection to preclinical evaluation was unprecedented and highlights the extraordinary ecosystem of technologies available to scientists…

Impact of E-Cigarette Smoke on Cardiovascular Function

Cigarette smoking is one of the primary risk factors for cardiovascular disease (CVD). In fact, the American Heart Association reports that smoking-related diseases are responsible for > 440,000 deaths in the US each year. Cigarette smoke contains hundreds of chemical toxicants, which can damage the cardiovascular system, and increase the risk of developing atherosclerosis. Atherosclerosis…

Drug Repurposing to Treat COVID-19 Induced Lung Injury

The rapid spread of COVID-19 during the global pandemic has led many scientists and researchers to look towards repurposing existing FDA-approved drugs, outside the scope of their originally designated purposes, to expedite the delivery of effective treatments on the shortened time-scale required to treat COVID-19 patients owing to their proven safe for human use in…

Thawing and Seeding Lifeline Primary Cells

Main Menu